MANDIE MILLER: Open Payments
NPI 1609152479 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,233 in 127 payments from 15 companies in 2025. Trend: 2023 $1,720 · 2024 $2,457 · 2025 $2,233
Food & beverage: $2,122Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $427 |
| Lundbeck LLC | 11 | $243 |
| Otsuka America Pharmaceutical, Inc. | 13 | $223 |
| Vanda Pharmaceuticals Inc. | 9 | $191 |
| Teva Pharmaceuticals USA, Inc. | 8 | $189 |
| Axsome Therapeutics, Inc. | 11 | $185 |
| Neurocrine BioSciences, Inc. | 14 | $183 |
| ABBVIE INC. | 11 | $176 |
| E.R. Squibb & Sons, L.L.C. | 10 | $139 |
| Alkermes, Inc. | 6 | $100 |
Products named: REXULTI, CAPLYTA, Auvelity, INGREZZA, VRAYLAR, FANAPT, COBENFY, ARISTADA.
Industry payments across AZ — which companies pay providers there.
